International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(22), С. 12174 - 12174
Опубликована: Ноя. 13, 2024
Minimal
Change
Disease
(MCD)
is
a
predominant
cause
of
idiopathic
nephrotic
syndrome
in
the
pediatric
population,
yet
presents
significant
clinical
challenges
due
to
its
frequent
relapses
and
steroid
resistance.
Despite
relatively
benign
histological
appearance,
MCD
characterized
by
severe
proteinuria,
hypoalbuminemia,
edema,
which
may
affect
patient
outcomes.
Current
treatment
strategies
primarily
rely
on
corticosteroids,
are
effective
inducing
remission
but
associated
with
high
relapse
rates,
resistance,
numerous
long-term
side
effects,
underscoring
need
for
more
targeted
therapeutic
approaches.
This
narrative
review
synthesizes
current
knowledge
pathophysiological
mechanisms
underlying
MCD,
focusing
following
three
critical
areas:
podocyte
dysfunction,
immune
dysregulation,
genetic
susceptibility.
Podocyte
particularly
involving
alterations
nephrin,
plays
central
role
breakdown
glomerular
filtration
barrier,
leading
characteristic
proteinuria
observed
MCD.
Immune
including
presence
autoantibodies
against
nephrin
other
components,
exacerbates
injury
contributes
disease
progression,
suggesting
an
autoimmune
component
disease.
Genetic
factors,
mutations
NPHS1
NPHS2
genes,
have
been
identified
as
contributors
susceptibility,
influencing
variability
response
overall
severity.
Understanding
these
crucial
developing
therapies
that
address
causes
rather
than
merely
managing
symptoms.
highlights
further
research
into
processes
pave
way
personalized
strategies,
ultimately
improving
outcomes
reducing
reliance
corticosteroids.
Abstract
Membranous
nephropathy
(MN),
an
autoimmune
disease,
can
manifest
at
any
age
and
is
among
the
most
common
causes
of
nephrotic
syndrome
in
adults.
In
80%
cases,
specific
etiology
MN
remains
unknown,
while
remaining
cases
are
linked
to
drug
use
or
underlying
conditions
like
systemic
lupus
erythematosus,
hepatitis
B
virus,
malignancy.
Although
about
one‐third
patients
may
achieve
spontaneous
complete
partial
remission
with
conservative
management,
another
third
face
elevated
risk
disease
progression,
potentially
leading
end‐stage
renal
within
10
years.
The
identification
phospholipase
A2
receptor
as
primary
target
antigen
has
brought
a
significant
shift
management
monitoring.
This
review
explores
recent
advancements
pathophysiology
MN,
encompassing
pathogenesis,
clinical
presentations,
diagnostic
criteria,
treatment
options,
prognosis,
focus
on
emerging
developments
pathogenesis
therapeutic
strategies
aimed
halting
progression.
By
synthesizing
latest
research
findings
insights,
this
seeks
contribute
ongoing
efforts
enhance
our
understanding
challenging
disorder.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 7, 2025
Chronic
kidney
disease
(CKD)
is
a
worldwide
public
health
problem.
Podocyte
damage
hallmark
of
glomerular
diseases
including
focal
segmental
glomerulosclerosis
(FSGS)
and
one
the
leading
causes
CKD.
Lysine
methylation
crucial
post-translational
modification.
Beyond
epidemic
regulation,
various
lysine
methyltransferases
have
been
recently
reported
to
participate
in
progression,
cancers
diseases.
Among
them,
Methyltransferase-like
10
(METTL10),
recognized
as
gene
associated
with
estimated
filtration
rate
(eGFR)
CKD
risk.
However,
its
role
podocyte
remains
unclear.
We
identified
differentially
expressed
genes(DEGs)in
injury
by
bioinformatics
analysis.
Patients
diagnosed
idiopathic
FSGS
renal
biopsy
were
enrolled.
Mouse
model
was
established
Adriamycin(ADR)
urinary
albumin/
creatinine
ratio(UACR)
detected.
Murine
cell
line
stimulated
ADR.
determined
METTL10
significantly
downregulated
genes
damaged
podocytes,
confirmed
decreased
expression
patients
mice
ADR-induced
nephrosis,
respectively.
Moreover,
we
found
negative
correlation
between
levels
UACR
mice.
reduced
ADR-treated
accompanied
dedifferentiation
(loss
synaptopodin,
podocin,
nephrin,
WT-1)
acquisition
mesenchymal
markers
(snail,
desmin,
pax2).
Knockdown
promoted
their
dedifferentiation.
regulates
under
damaging
stimuli
protects
podocytes.
World Journal of Nephrology,
Год журнала:
2025,
Номер
14(1)
Опубликована: Янв. 18, 2025
The
underlying
molecular
changes
that
result
in
minimal
change
disease
(nephrotic
syndrome)
require
an
in-depth
analysis.
Current
studies
have
shown
the
involvement
of
zinc
fingers
and
homeobox
transcriptional
factors
its
pathogenesis.
application
therapeutic
drugs
relies
on
understanding
cascade
events
to
determine
their
efficacy
managing
clinical
condition.
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Янв. 21, 2025
The
endoplasmic
reticulum
(ER)
is
a
vital
organelle
responsible
for
protein
quality
control,
including
the
folding,
modification,
and
transport
of
proteins.
When
misfolded
or
unfolded
proteins
accumulate
in
ER,
it
triggers
stress
(ERS)
activates
response
(UPR)
to
restore
ER
homeostasis.
However,
prolonged
excessive
ERS
can
lead
apoptosis.
kidneys
play
crucial
role
maintaining
physiological
functions
by
excreting
metabolic
waste,
regulating
blood
volume,
balancing
electrolytes
acid-base
levels,
secreting
various
bioactive
substances.
Podocytes,
epithelial
cells
situated
outside
glomerular
basement
membrane,
are
essential
structural
integrity
permeability
filtration
barrier.
Previous
studies
have
shown
that
podocytes
contribute
development
diseases
such
as
glomerulonephritis,
hereditary
nephropathy,
diabetic
kidney
disease,
potentially
progressing
end-stage
renal
disease
causing
patient
mortality.
As
such,
investigating
has
become
key
area
focus
research.
This
study
examines
recent
advancements
understanding
effects
on
across
diseases,
highlights
podocyte
progression,
explores
potential
therapeutic
benefits
targeting
UPR
manage
thereby
providing
scientific
basis
clinical
interventions.
Genes,
Год журнала:
2025,
Номер
16(3), С. 241 - 241
Опубликована: Фев. 20, 2025
Background/Objectives:
Autoimmunity
towards
podocyte
antigens
causes
membranous
nephropathy
(MN).
Numerous
MN
target
(MNTAgs)
have
been
reported,
including
PLA2R1,
THSD7A,
NTNG1,
TGFBR3,
HTRA1,
NDNF,
SEMA3B,
FAT1,
EXT1,
CNTN1,
NELL1,
PCDH7,
EXT2,
PCSK6,
and
NCAM1,
but
their
expression
has
not
thoroughly
studied.
Methods:
We
screened
CZ
CELLxGene
single-cell
RNA
(scRNA)
sequence
datasets
for
those
of
adult,
fetal,
mouse
kidneys
analyzed
the
above
MNTAgs’
expression.
Results:
In
adult
kidneys,
most
MNTAgs
are
present
in
podocytes,
except
PCSK6
NCAM1.
PLA2R1
is
expressed
significantly
more
than
other
podocytes
a
major
marker,
consistent
with
as
dominant
MNTAg.
Additionally,
top-upregulated
gene
chronic
kidney
disease,
acute
injury,
diabetic
nephropathy,
indicating
its
general
role
causing
injury.
NDNF
display
podocyte-enriched
along
elevated
chromatin
accessibility
suggesting
transcription
initiation
contributing
to
preference
podocytes.
fetal
kidney,
While
weakly
SEMA3B
abundantly
immature
mature
supporting
childhood
Thsd7a
only
MNTAg
prominent
level
podocyte-specific
Conclusions:
Most
adults
during
renal
development.
adults,
highly
enriched
upregulated
multiple
diseases
accompanied
by
proteinuria.
specifically
at
an
level.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(6), С. 2450 - 2450
Опубликована: Март 9, 2025
Podocyte
injury
plays
a
central
role
in
both
focal
segmental
glomerulosclerosis
(FSGS)
and
minimal
change
disease
(MCD).
Pathogenic
mechanisms
are
diverse
incompletely
understood,
partially
overlap
between
FSGS
MCD,
not
reflected
by
kidney
biopsy.
In
order
to
optimize
the
current
variable
response
treatment,
personalized
management
should
rely
on
pathogenesis.
One
promising
approach
involves
identifying
biomarkers
associated
with
specific
pathogenic
pathways.
With
advancement
of
technology,
proteomic
studies
could
be
valuable
tool
improve
knowledge
this
area
define
valid
biomarkers,
as
they
have
other
areas
glomerular
disease.
This
work
attempts
cover
discuss
main
podocyte
injury,
followed
review
recent
literature
biomarker
podocytopathies.
Most
these
been
conducted
biofluids,
while
tissue
applied
podocytopathies
remain
limited.
While
we
recognize
importance
non-invasive
biofluid
propose
sequential
for
their
development:
proteomics
first
identify
proteins
increased
expression
that
may
reflect
underlying
mechanisms;
subsequently,
validation
urine
or
plasma
pave
way
diagnostic
prognostic
biomarker-based
approach.
Immunological Investigations,
Год журнала:
2025,
Номер
unknown, С. 1 - 25
Опубликована: Апрель 21, 2025
Antibodies
have
long
served
as
fundamental
tools
in
disease
diagnosis
and
surveillance.
Their
utility
biomarkers
has
expanded
beyond
infectious
diseases
to
encompass
a
wide
range
of
health
conditions.
This
review
aims
explore
recent
advancements
antibody
biomarker
discovery
their
applications
diagnosing
monitoring
diverse
It
also
examines
the
role
surveillance
public
epidemiological
studies.
A
comprehensive
analysis
literature
was
conducted,
focusing
on
studies
that
identify
characterize
disease-specific
antibodies.
Particular
attention
given
relevance
autoimmune
diseases,
infections,
cancers,
neurological
disorders.
The
highlights
clinical
significance.
discusses
challenges
antibody-based
assessing
prevalence,
tracking
immunity
trends,
supporting
One
Health
strategies.
Recent
demonstrate
significant
potential
improving
early
diagnosis,
personalized
treatment,
population-level
management.
Antibody
continues
play
pivotal
guiding
responses
understanding
dynamics.
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Май 9, 2025
Introduction
Sanqi
oral
solution
(SQ)
is
a
Chinese
medicine
that
has
been
used
well
to
treat
idiopathic
membranous
nephropathy
(IMN).
It
demonstrated
mitigate
IMN
proteinuria
by
inhibiting
podocyte
apoptosis.
however,
the
precise
mechanism
not
fully
elucidated.
Methods
A
passive
Heymann
(PHN)
rat
model
was
mimic
in
vivo
disease
characteristics
of
IMN.
The
PHN
rats
were
intragastrically
administered
SQ
(12.6/6.3
mL/kg)
or
tacrolimus
(0.315
mg/kg)
for
21
days.
applied
ADR-induced
podocytes
vitro
.
effects
on
and
its
underlying
mechanisms
determined
measuring
biochemical
indices,
pathomorphological
characteristics,
membrane
attack
complex
(MAC),
cell
morphology,
protein
levels.
Results
ingredients
found
serum
underscored
their
successful
absorption
rats.
In
rats,
induced
significant
reduction
proteinuria,
MAC,
C5b-9,
glomerular
basement
thickness,
along
with
drop
apoptotic
podocytes.
Similarly,
exerted
protective
effect
against
injury
Furthermore,
inhibition
ERK/CK2-α/β-catenin
pathway-mediated
epithelial-to-mesenchymal
transition
(EMT)
be
involved
anti-apoptotic
podocytes,
marked
vimentin
α-SMA
induction
Synaptopodin
Podocin
Conclusion
Inhibition
EMT
via
pathway
may
main
which
suppresses
apoptosis